AZD3514

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Prostate Cancer

Phase 1

Open Label Prostate Cancer Study

CompletedNCT01162395

AstraZenecaProstate Cancer

Start: 2010-08-31End: 2015-10-31Updated: 2016-01-12

An Open Label Prostate Cancer Study in Japanese Patients

CompletedNCT01351688

AstraZenecaProstate Cancer

Start: 2011-08-31End: 2013-05-31Updated: 2013-07-03

Related Papers

Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.

2016-08-315 citations